Cargando…
Zafirlukast inhibits the growth of lung adenocarcinoma via inhibiting TMEM16A channel activity
Lung cancer has the highest mortality among cancers worldwide due to its high incidence and lack of the effective cures. We have previously demonstrated that the membrane ion channel TMEM16A is a potential drug target for the treatment of lung adenocarcinoma and have identified a pocket of inhibitor...
Autores principales: | Shi, Sai, Ma, Biao, Sun, Fude, Qu, Chang, Li, Gen, Shi, Donghong, Liu, Wenxin, Zhang, Hailin, An, Hailong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931426/ https://www.ncbi.nlm.nih.gov/pubmed/35176281 http://dx.doi.org/10.1016/j.jbc.2022.101731 |
Ejemplares similares
-
Theaflavin binds to a druggable pocket of TMEM16A channel and inhibits lung adenocarcinoma cell viability
por: Shi, Sai, et al.
Publicado: (2021) -
Recent progress in structural studies on TMEM16A channel
por: Shi, Sai, et al.
Publicado: (2020) -
Inhibition of TMEM16A by Natural Product Silibinin: Potential Lead Compounds for Treatment of Lung Adenocarcinoma
por: Guo, Shuai, et al.
Publicado: (2021) -
Identification of a druggable pocket of the calcium-activated chloride channel TMEM16A in its open state
por: Shi, Sai, et al.
Publicado: (2023) -
Zafirlukast
Is a Promising Scaffold for Selectively
Inhibiting TNFR1 Signaling
por: Vunnam, Nagamani, et al.
Publicado: (2023)